The impact of S2 mutations on Omicron SARS-CoV-2 cell surface expression and fusogenicity

Alba Escaleraa Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA;b Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA;c Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USAView further author information

Manon Laportea Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA;b Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USAView further author information

Sam Turnerd Center for Pathogen Evolution, Department of Zoology, University of Cambridge, Cambridge, UKView further author information

Umut Karakusa Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA;b Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USAView further author information

Ana S. Gonzalez-Reichee Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USAView further author information

Adriana van de Guchtee Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USAView further author information

Keith Farrugiae Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USAView further author information

Zain Khalile Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USAView further author information

Harm van Bakela Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA;e Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA;f Icahn Genomics Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USAView further author information

Derek Smithd Center for Pathogen Evolution, Department of Zoology, University of Cambridge, Cambridge, UKView further author information

Adolfo García-Sastrea Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA;b Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA;g Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA;h Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA;i The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USACorrespondence[email protected]
View further author information

Teresa Aydilloa Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA;b Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USACorrespondence[email protected]
View further author information

show all

The impact of S2 mutations on Omicron SARS-CoV-2 cell surface expression and fusogenicity

SupFigures_R1

SupTable1_R1

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The impact of S2 mutations on Omicron SARS-CoV-2 cell surface expression and fusogenicity

SupFigures_R1

SupTable1_R1

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date